Skip to content
Homepage
Author:
Unlearn AI
Posted Date:
July 9, 2026
Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses of Alzheimer’s Disease Clinical Programs
Unlearn AI
July 9, 2026
Unlearn to Support SOLA Biosciences’ Clinical Study Using AI-Generated Digital Twins
Unlearn AI
March 10, 2026
Unlearn Advances Huntington’s Disease AI Modeling Through Access to CHDI Foundation Data
Unlearn AI
February 24, 2026
Unlearn to Apply AI-Generated Digital Twins to the VectorY Therapeutics PIONEER-ALS Study
Unlearn AI
February 12, 2026
Unlearn Introduces TrialPioneer, an AI-powered Workspace to Strengthen Upstream Trial Planning
Unlearn AI
January 28, 2026
